feed,title,long_url,short_url
Benzinga,EXCLUSIVE: Alzamend Neuro Starts Phase 1/2A Trial For Its Alzheimer's Immunotherapy Vaccine,https://benzinga.com/general/biotech/23/04/31626639/exclusive-alzamend-neuro-starts-phase-12a-trial-for-its-alzheimers-immunotherapy-vaccine,https://da.gd/eAxQ
Benzinga,"Additional Data From Travere Therapeutics' Kidney Disease Candidate Reinforce Efficacy, Supporting Ongoing Launch",https://benzinga.com/general/biotech/23/04/31628166/additional-data-from-travere-therapeutics-kidney-disease-candidate-reinforce-efficacy-supporting-,https://da.gd/eAZyw
